{"id":"W2340806160","doi":"10.1136/rmdopen-2015-000210","title":"Reductions in disease activity in the AMPLE trial: clinical response by baseline disease duration","year":2016,"lang":"en","type":"article","venue":"RMD Open","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada; Sanofi; Amgen; Pfizer; Genentech; Celgene; AstraZeneca; Coherus Biosciences; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Adalimumab; Abatacept; Internal medicine; Rheumatoid arthritis; Methotrexate; Post-hoc analysis; Rheumatology; Clinical trial; Disease; Physical therapy; Rituximab","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004045613,0.00008848956,0.0002065237,0.0000824458,0.00008245249,0.00007422996,0.0002405448,0.00003425647,0.0003377571],"category_scores_gemma":[0.006562673,0.00004920192,0.00006943271,0.0002123038,0.0001348313,0.0003564131,0.00008145866,0.0001720232,0.00006474277],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005898012,"about_ca_system_score_gemma":0.0004566057,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003197413,"about_ca_topic_score_gemma":0.0003357492,"domain_scores_codex":[0.9970266,0.00186165,0.0003511943,0.0002697111,0.0002690108,0.0002218295],"domain_scores_gemma":[0.9979653,0.001160541,0.00005686885,0.0004813014,0.00004074137,0.000295297],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8096701,0.003517533,0.04563181,0.00001747309,0.00003280595,0.0002329648,0.0003410355,9.780301e-7,0.003413628,0.0002813399,0.06868165,0.06817869],"study_design_scores_gemma":[0.09654512,0.0009690332,0.5591619,0.0004278078,0.000009386718,0.000005969824,0.0001952916,0.0001917521,0.0001152639,0.001793331,0.3403829,0.0002022127],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.90137,0.00046285,0.00008980588,0.09606712,0.00008667939,0.001711216,0.0001286771,0.00001446311,0.00006915158],"genre_scores_gemma":[0.9950473,0.003133922,0.00003093585,0.0004202069,0.0000913622,0.0003465438,0.00004410872,0.0000122634,0.0008733023],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.713125,"threshold_uncertainty_score":0.7856607,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07824353202588688,"score_gpt":0.4242618937616006,"score_spread":0.3460183617357138,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}